Applied Molecular Transport Company Profile, Contacts & Intelligence

BiotechnologySouth San Francisco, California, United States10 employeesFounded 2015
3 contacts with email or phone data3 with email data
Employees
10
Company source estimate
Reachable Contacts
3
Visible contacts with email or phone data
Contacts With Email
3
3 of 3 visible contacts
Departments
1
Mapped contact coverage

Applied Molecular Transport Overview

Applied Molecular Therapeutics (AMT), a public biopharmaceutical company based in South San Francisco, California, is committed to developing novel, oral biological therapeutics to treat severe autoimmune, metabolic and inflammatory diseases. AMT is leveraging its propriety technology platforms to create gastrointestinal (GI)-select therapeutics that harness naturally occurring transport and targeting mechanisms to cross the protective barrier of the intestinal epithelium (IE). Once across the IE, the therapeutics gain privileged access to the immune cell-rich environment of the GI tissue as well as the hepatic portal system and downstream systemic circulation. With this privileged access, AMT’s goal is to develop transformative new oral therapeutic treatment options that offer patients greater efficacy and tolerability than available with today’s therapeutics. AMT has a robust pipeline of oral biologic product opportunities, including AMT-101 which is currently in Phase 1b clinical development for the treatment of adults with ulcerative colitis (UC). AMT-101 is a novel, gut-selective, investigational oral biologic fusion protein of interleukin 10 (IL-10), an anti-inflammatory cytokine. Derived from AMT’s proprietary platforms, AMT-101 is engineered to cross the selective barrier of the IE and enhance localized IL-10 directly within the immune-cell rich environment of GI tissue where up to 75 percent of immune cells reside. This direct targeting of the immune system creates the potential for AMT-101 to address, at its point of origin, the immune dysregulation that gives rise to UC and other inflammatory bowel diseases, and restore immune homeostasis with minimal systemic exposure and potentially fewer adverse events compared to systemic administration of IL-10. AMT has amassed a broad global IP portfolio surrounding its multiple technology platforms and therapeutic programs.

Headquarters
South San Francisco, California, United States
Industry
Biotechnology
Founded
2015
Phone Number
Available in AeroLeads
Company Email
Available in AeroLeads

Applied Molecular Transport Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

3 contacts with contact data
3 with email data in the visible sample.
1 department represented
Visible contacts with email or phone data are mapped to these departments.
3 company-domain emails
Visible contacts using Applied Molecular Transport's company email domain.
General
3

Applied Molecular Transport People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Applied Molecular Transport Workforce Composition

Seniority breakdown across 9 visible profiles.

Individual contributor
5
Manager
3
Intern / trainee
1

Applied Molecular Transport Technology & Talent

Technology-related job titles represented in the visible people data.

Cloud / infrastructure
1
Data / AI
1

Compare Similar Companies to Applied Molecular Transport

Explore companies in related markets and compare their industry and employee estimates.

Company Industry / match Employee estimate Page
Genentech Biotechnology Research 18.23K View company
Gilead Sciences Biotechnology Research 14.65K View company
BridgeBio Biotechnology Research 778 View company
Allogene Therapeutics Biotechnology 222 View company
Alumis Biotechnology Research 216 View company
Vera Therapeutics, Inc. Biotechnology Research 194 View company
Mindera Health Biotechnology 30 View company
Cyclo Therapeutics, Inc. Pharmaceutical Manufacturing 19 View company
ENDPOINT HEALTH Biotechnology Research 12 View company
Ensho Therapeutics Biotechnology Research 9 View company